Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
glioblastoma
Research
CAR-T for brain cancer extends survival in phase 1 trial
Mustang Bio and City of Hope’s CAR-T therapy for glioblastoma led to stable disease in half of the subjects, with one surviving beyond five years.
Helen Floersh
Mar 12, 2024 9:00am
'Quantum therapeutic' sparks glioblastoma cells to self-destruct
Sep 18, 2023 11:00am
ASCO: Servier finds survival benefit in difficult brain cancer
Jun 5, 2023 8:55am
Kazia dropped from global umbrella trial to treat brain cancer
Aug 1, 2022 1:45pm
How a vitamin might help fight glioblastoma
Apr 1, 2020 2:00pm
Blocking DNA-repairing protein could help beat glioblastoma
Jan 11, 2017 4:19pm